Priority procedures for medicaments: a demonstrated tool to expedite the examination of relevant patents to public health

• Published in: World patent information Vol. 70; p. 102131
• Main Authors: Pessôa, R.F., Correa, E.G., Vasconcellos, A.G.
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01-09-2022
• Subjects: Intellectual property of pharmaceutical products and processes; Pharmaceutical drugs; Unified health system; Patent; Unified health system; Intellectual property of pharmaceutical products and processes; Pharmaceutical drugs
• ISSN: 0172-2190; 1874-690X
• DOI: 10.1016/j.wpi.2022.102131

The delay in analyzing patent requests from the pharmaceutical area in Brazil and some vagueness in Brazil's Intellectual Property Law lead to a longer validity of many medicine patents, inhibiting generic drugs from being available in Brazil. Therefore, this investigation aims at: a) analyzing the effectiveness of priority procedures in patent processes requested by the Ministry of Health (Ministério da Saúde, MS) as a tool to make analyses faster; and b) assessing any synergy in the co-operation of MS, the National Institute of Industrial Property and the National Health Surveillance Agency, which decreased the necessary time to finish the analysis in both institutions.